DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Lip GY, Halperin JL, Petersen P, Rodgers GM, Pall D, Renfurm RW.
A Phase II, double-blind, randomized, parallel group, dose-finding study of the safety and tolerability of darexaban compared with warfarin in patients with non-valvular atrial fibrillation: the oral factor Xa inhibitor for prophylaxis of stroke in atrial fibrillation study 2 (OPAL-2).
J Thromb Haemost 2015;
13 (08) 1405-1413
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.